These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 33692334
21. Circ_0123996 promotes cell proliferation and fibrosisin mouse mesangial cells through sponging miR-149-5p and inducing Bach1 expression. Wang W, Feng J, Zhou H, Li Q. Gene; 2020 Nov 30; 761():144971. PubMed ID: 32707301 [Abstract] [Full Text] [Related]
23. LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486-5p/NFAT5. Duan YR, Chen BP, Chen F, Yang SX, Zhu CY, Ma YL, Li Y, Shi J. J Cell Mol Med; 2021 Jun 30; 25(11):4922-4937. PubMed ID: 33939247 [Abstract] [Full Text] [Related]
31. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation. Liu L, Wang Y, Yan R, Liang L, Zhou X, Liu H, Zhang X, Mao Y, Peng W, Xiao Y, Zhang F, Liu L, Shi M, Guo B. Life Sci; 2019 Dec 01; 238():116957. PubMed ID: 31655195 [Abstract] [Full Text] [Related]
32. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Zhao S, Li W, Yu W, Rao T, Li H, Ruan Y, Yuan R, Li C, Ning J, Li S, Chen W, Cheng F, Zhou X. Theranostics; 2021 Dec 01; 11(18):8660-8673. PubMed ID: 34522205 [Abstract] [Full Text] [Related]
33. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy. Gao BH, Wu H, Wang X, Ji LL, Chen C. Eur Rev Med Pharmacol Sci; 2020 Feb 01; 24(3):1338-1349. PubMed ID: 32096183 [Abstract] [Full Text] [Related]
34. Injured tubular epithelial cells activate fibroblasts to promote kidney fibrosis through miR-150-containing exosomes. Guan H, Peng R, Mao L, Fang F, Xu B, Chen M. Exp Cell Res; 2020 Jul 15; 392(2):112007. PubMed ID: 32315664 [Abstract] [Full Text] [Related]
35. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Nagaishi K, Mizue Y, Chikenji T, Otani M, Nakano M, Konari N, Fujimiya M. Sci Rep; 2016 Oct 10; 6():34842. PubMed ID: 27721418 [Abstract] [Full Text] [Related]
36. CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway. Bai X, Hou X, Tian J, Geng J, Li X. Oncotarget; 2016 Jun 14; 7(24):36510-36528. PubMed ID: 27145370 [Abstract] [Full Text] [Related]
37. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy. Liu H, Wang X, Liu S, Li H, Yuan X, Feng B, Bai H, Zhao B, Chu Y, Li H. Int J Biochem Cell Biol; 2016 Jan 14; 70():149-60. PubMed ID: 26646104 [Abstract] [Full Text] [Related]
38. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7. McClelland AD, Herman-Edelstein M, Komers R, Jha JC, Winbanks CE, Hagiwara S, Gregorevic P, Kantharidis P, Cooper ME. Clin Sci (Lond); 2015 Dec 14; 129(12):1237-49. PubMed ID: 26415649 [Abstract] [Full Text] [Related]
39. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway. Zhang Y. Biosci Rep; 2021 Sep 30; 41(9):. PubMed ID: 33729484 [Abstract] [Full Text] [Related]
40. Therapeutic potential of urine exosomes derived from rats with diabetic kidney disease. Mishra DD, Sahoo B, Maurya PK, Sharma R, Varughese S, Prasad N, Tiwari S. Front Endocrinol (Lausanne); 2023 Sep 30; 14():1157194. PubMed ID: 37251672 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]